{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:18:15Z","timestamp":1795094295941,"version":"4.10.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["PDEV-19141"],"award-info":[{"award-number":["PDEV-19141"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL181016"],"award-info":[{"award-number":["R01 HL181016"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL174996"],"award-info":[{"award-number":["R01 HL174996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.redox.2026.104394","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:31:19Z","timestamp":1789169479000},"page":"104394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1773","authenticated-orcid":false,"given":"Mahmoud H.","family":"Elbatreek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak S.","family":"Khodade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8665-5618","authenticated-orcid":false,"given":"Darshan","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Allerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Polhemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Vondriska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci T.","family":"Goodchild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10431","key":"10.1016\/j.redox.2026.104394_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2026.104394_bib2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ehf2.14302","article-title":"Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiac and non-cardiac mortality","volume":"10","author":"Shahim","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.redox.2026.104394_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.redox.2026.104394_bib4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s44161-025-00754-7","article-title":"Modeling HFpEF in animals","volume":"4","author":"Kass","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.redox.2026.104394_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028480","article-title":"Combination sodium nitrite and hydralazine therapy attenuates heart failure with preserved ejection fraction severity in a \"2-Hit\" murine model","volume":"12","author":"LaPenna","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"21","key":"10.1016\/j.redox.2026.104394_bib6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/bph.16493","article-title":"Adjunctive therapy with an oral H(2)S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction","volume":"181","author":"Doiron","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.redox.2026.104394_bib7","article-title":"Hydrogen sulfide deficiency and therapeutic targeting in cardiometabolic HFpEF: evidence for synergistic benefit with GLP-1\/Glucagon agonism","volume":"10","author":"Doiron","year":"2025","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.redox.2026.104394_bib8","series-title":"Low Dose GLP-1 Therapy Attenuates Pathological Cardiac and Hepatic Remodelling in HFpEF Independent of Weight Loss","author":"Elbatreek","year":"2025"},{"issue":"9","key":"10.1016\/j.redox.2026.104394_bib9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.124.326042","article-title":"Dysregulated protein s-Nitrosylation promotes nitrosative stress and disease progression in heart failure with preserved ejection fraction","volume":"137","author":"Li","year":"2025","journal-title":"Circ. Res."},{"issue":"19","key":"10.1016\/j.redox.2026.104394_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017544","article-title":"Endothelial cell cystathionine gamma-Lyase expression level modulates exercise capacity, vascular function, and myocardial ischemia reperfusion injury","volume":"9","author":"Xia","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.redox.2026.104394_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCRESAHA.122.321326","article-title":"Hydrogen sulfide modulates endothelial-mesenchymal transition in heart failure","volume":"132","author":"Li","year":"2023","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.redox.2026.104394_bib12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41569-026-01257-z","article-title":"HFpEF and MASLD: converging mechanisms and clinical implications","volume":"23","author":"Capone","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"issue":"18","key":"10.1016\/j.redox.2026.104394_bib13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.redox.2026.104394_bib14","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.redox.2026.104394_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.redox.2026.104394_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/CIRCULATIONAHA.124.072679","article-title":"Effects of tirzepatide on the clinical trajectory of patients with heart failure, preserved ejection fraction, and obesity","volume":"151","author":"Zile","year":"2025","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.redox.2026.104394_bib17","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1038\/s41467-025-59616-2","article-title":"Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study","volume":"16","author":"Lin","year":"2025","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.redox.2026.104394_bib18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.2025.14092","article-title":"Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction","volume":"334","author":"Kruger","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.redox.2026.104394_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.redox.2026.104394_bib20","doi-asserted-by":"crossref","first-page":"H971","DOI":"10.1152\/ajpheart.2000.278.3.H971","article-title":"Modulation of mouse cardiac function in vivo by eNOS and ANP","volume":"278","author":"Gyurko","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2026.104394_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/HJH.0b013e3283450770","article-title":"Endothelin-1 overexpression restores diastolic function in eNOS knockout mice","volume":"29","author":"Vignon-Zellweger","year":"2011","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.redox.2026.104394_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI21968","article-title":"Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load","volume":"115","author":"Takimoto","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.redox.2026.104394_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.resuscitation.2010.08.038","article-title":"Genetic deletion of NOS3 increases lethal cardiac dysfunction following mouse cardiac arrest","volume":"82","author":"Beiser","year":"2011","journal-title":"Resuscitation"},{"key":"10.1016\/j.redox.2026.104394_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8309698","article-title":"Nrf2 deficiency unmasks the significance of nitric oxide synthase activity for cardioprotection","volume":"2018","author":"Erkens","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.redox.2026.104394_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12012-007-0028-y","article-title":"eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression","volume":"7","author":"Flaherty","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.redox.2026.104394_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/FJC.0000000000000763","article-title":"Important roles of endothelium-dependent hyperpolarization in coronary microcirculation and cardiac diastolic function in mice","volume":"75","author":"Ikumi","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:29:47Z","timestamp":1795091387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S2213231726003939"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104394","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104394"}}